Product range

Composition

  • Cross-linked HA of 4D-matrix.
  • Saline solution – 1.0 ml.
  • Lidocaine – 0.3%.
  • BDDE stabilizer.

About PHILLEX

Phillex – new generation of intradermal fillers based on stabilized hyaluronic acid of non-animal origin.
Phillex – due to innovative method of production it was possible to obtain spherical molecules of hyaluronic acid with higher-order and dense grid (see fig.3).
Phillex – first medical product with spatial ordering of molecules of hyaluronic acid (4D-matrix technology). Due to production technology of spherical molecules, PHILLEX not just removes skin defects (3D-matrix mechanism) but also allows to resist compression load (effect of "spring", 4D-matrix), which, in turn, results in greater facial tissues lifting.
Phillex – showed its effectiveness and safety, proved by a series of comparative clinical studies conducted with Restylane (Qmed, Sweden) (see fig.1,2).

Specific features: 3. Comparative diagram of pain during injection

   
Phillex™ –contains 0.3% of lidocaine, which relieves pain suffered by the patients during or after injection; laser needle sharpening allows to minimize pain during initial injection.

 

Safety and efficiency

Clinical studies results, which have proven their safety and effectiveness

Clinical studies of the medical product Phillex ™ have proven their effectiveness and safety for nasolabial folds correction.

Phillex ™ does not come short to the reference medical product Restylane® (Qmed, Sweden).

Comparative table of GAIS** results, obtained by the researcher on the 8th, 16th, and 24th week of FAS* Fig.1 Comparative table of GAIS** results, obtained by the research subjects on the 8th, 16th, and 24th week of FAS* Fig.2
GAIS** GAIS**
Period of time
Number of patients
Tested product (PhillexTM Deep) Control item (Restylane® Deep) Period of time Number of patients Tested product (PhillexTM Deep) Control item (Restylane® Deep)
n Mean±SD Mean±SD n Mean±SD Mean±SD
8th week 66 2.12±0.48 2.08±0.51 8th week 66 2.15±0.50 2.08±0.51
16th week 66 2.06±0.49 2.02±0.51 16th week 66 2.06±0.49 2.02±0.51
24th week 66 1.65±0.71 1.64±0.72 24th week 66 1.65±0.71 1.64±0.72

 

Specific features: 1. Monophasic spherical structure

Phillex™ has a regular, spherical and dense grid comparing with other fillers, ensures continuous and easy injection throughout the entire process of volumization and helps to ensure natural and harmonized appearance.

Product-J
Product-Phillex
Product-P

Specific features: 1. Monophasic spherical structure

Phillex™ has a regular, spherical and dense grid comparing with other fillers, ensures continuous and easy injection throughout the entire process of volumization and helps to ensure natural and harmonized appearance.

Specific features: 2. Comparative characteristics of efforts in medical products extrusion for contour correction

 
 
Phillex™ – extrusion strength of this medical product allows the doctors to easily and safely control injections throughout the entire procedure.

 

Participants of the study

66 participants scored 3 or 4 points by GAIS Scale . Target: eliminate nasolabial folds.

Methodology

Arbitrary sampling; diversified blind study. Control of efficiency and safety of comparing with Restylane® (Q Med, Sweden).

Conclusions

Clinical studies have confirmed that (Deep) is safe and efficient medical product for nasolabial folds correction and does not come short to the reference medical product Restylane®.
1 Results of clinical studies made by Dongkook Pharmaceutical Co., Ltd.
* FAS* = a set of data for a full analysis; ** GAIS ** Global Aesthetic Improvement Scale

Product range

 
Composition Per 24 mg/ml,
0.3% lidocaine
Per 24 mg/ml,
0.3% lidocaine
Per 24 mg/ml,
0.3% lidocaine
Areas of injection Wrinkles: “crow’s feet”, perioral and periorbital wrinkles, lip contour, neck wrinkles, nasolacrimal groove Deep naso-labial folds, marionette lines, volume and contour of lips Deep folds and wrinkles: malar region, chin, cheeks, nasal correction
Injection depth Epidermis, upper dermis Middle/deep layer of derma Deep layer of derma/hypoderm
Syringe volume 1.1 ml 1.1 ml 1.1 ml
Needle size 30G/27G 27G 25G/27G
Storage - 2-25˚C -
Duration of procedures - 12-18 months -
BDDE - not found -
Shelf life - 24 months -

 

Results of clinical studies proving the safety and efficiency

The clinical studies of medical product PhillexTM proved its efficiency and safety for correction of naso-labial folds.

PhillexTM is highly competitive with the medical product Restylane® (Qmed, Sweden).

See more about results of clinical studies